BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 2330548)

  • 1. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
    Pearce N; Grainger J; Atkinson M; Crane J; Burgess C; Culling C; Windom H; Beasley R
    Thorax; 1990 Mar; 45(3):170-5. PubMed ID: 2330548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribed fenoterol and death from asthma in New Zealand, 1981-83: case-control study.
    Crane J; Pearce N; Flatt A; Burgess C; Jackson R; Kwong T; Ball M; Beasley R
    Lancet; 1989 Apr; 1(8644):917-22. PubMed ID: 2565417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study.
    Grainger J; Woodman K; Pearce N; Crane J; Burgess C; Keane A; Beasley R
    Thorax; 1991 Feb; 46(2):105-11. PubMed ID: 2014490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescribed drug therapy and near-fatal asthma attacks.
    Burgess C; Pearce N; Thiruchelvam R; Wilkinson R; Linaker C; Woodman K; Crane J; Beasley R
    Eur Respir J; 1994 Mar; 7(3):498-503. PubMed ID: 8013608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confounding by severity does not explain the association between fenoterol and asthma death.
    Beasley R; Burgess C; Pearce N; Woodman K; Crane J
    Clin Exp Allergy; 1994 Jul; 24(7):660-8. PubMed ID: 7953948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of salmeterol and near-fatal attacks of asthma.
    Williams C; Crossland L; Finnerty J; Crane J; Holgate S; Pearce N; Beasley R
    Thorax; 1998 Jan; 53(1):7-13. PubMed ID: 9577515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of severe life threatening asthma and beta agonist type: an example of confounding by severity.
    Garrett JE; Lanes SF; Kolbe J; Rea HH
    Thorax; 1996 Nov; 51(11):1093-9. PubMed ID: 8958891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma.
    Crane J; Pearce N; Burgess C; Woodman K; Robson B; Beasley R
    Int J Epidemiol; 1992 Aug; 21(4):737-44. PubMed ID: 1521979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists.
    Suissa S; Ernst P; Boivin JF; Horwitz RI; Habbick B; Cockroft D; Blais L; McNutt M; Buist AS; Spitzer WO
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):604-10. PubMed ID: 8118625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. End of the New Zealand asthma mortality epidemic.
    Pearce N; Beasley R; Crane J; Burgess C; Jackson R
    Lancet; 1995 Jan; 345(8941):41-4. PubMed ID: 7799709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992.
    Lanes SF; Birmann B; Raiford D; Walker AM
    J Clin Epidemiol; 1997 Mar; 50(3):321-8. PubMed ID: 9120532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albuterol and deaths from asthma in New Zealand from 1969 to 1976: a case-control study.
    Woodman K; Pearce N; Beasley R; Burgess C; Crane J
    Clin Pharmacol Ther; 1992 May; 51(5):566-71. PubMed ID: 1587070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of beta-agonists and the risk of death and near death from asthma.
    Spitzer WO; Suissa S; Ernst P; Horwitz RI; Habbick B; Cockcroft D; Boivin JF; McNutt M; Buist AS; Rebuck AS
    N Engl J Med; 1992 Feb; 326(8):501-6. PubMed ID: 1346340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical illusions from visual data analysis: example of the New Zealand asthma mortality epidemic.
    Suissa S; Ernst P
    J Clin Epidemiol; 1997 Oct; 50(10):1079-88. PubMed ID: 9368515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fenoterol and asthma mortality in New Zealand.
    Pearce N; Crane J; Burgess C; Grainger J; Beasley R
    N Z Med J; 1990 Feb; 103(884):73-5. PubMed ID: 2308729
    [No Abstract]   [Full Text] [Related]  

  • 16. The self-administration of inhaled beta agonist drugs during severe asthma.
    Windom HH; Burgess CD; Crane J; Pearce N; Kwong T; Beasley R
    N Z Med J; 1990 May; 103(889):205-7. PubMed ID: 2342689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81.
    Spitzer WO; Buist AS
    Thorax; 1990 Aug; 45(8):645-6. PubMed ID: 2402734
    [No Abstract]   [Full Text] [Related]  

  • 18. Low-dose inhaled corticosteroids and the prevention of death from asthma.
    Suissa S; Ernst P; Benayoun S; Baltzan M; Cai B
    N Engl J Med; 2000 Aug; 343(5):332-6. PubMed ID: 10922423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The severity of asthma in relation to beta agonist prescribing.
    Garrett JE; Turner P
    N Z Med J; 1991 Feb; 104(905):39-40. PubMed ID: 1671713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical complexity and epidemiologic uncertainty in case-control research. Fenoterol and asthma management.
    Horwitz RI; Spitzer W; Buist S; Cockcroft D; Ernst P; Habbick B; Hemmelgarn B; McNutt M; Rebuck AS; Suissa S
    Chest; 1991 Dec; 100(6):1586-91. PubMed ID: 1959400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.